CD8A and neoplasm: Additionally, the level of CD3+CD8+ T lymphocytes infiltrated in the tumor were found to be 78.81% (±6.89) in the PSPEI-PAA nanocomplex treatment group, whereas in PIC-lysate protein treatment group has 24.76% (±4.32) only (Figure 7b).